-
Non Regulatory November 27, 2020Oasmia appoints Robert Maiorana as acting CFO
-
Regulatory November 20, 2020Nomination Committee appointed for the 2021 Annual General Meeting in Oasmia
-
Non Regulatory November 3, 2020Oasmia to present at Investival Showcase November 11-16
Oasmia Pharmaceutical published its Q1 report on September 9, 2020, at 08.00 am CEST.
Oasmia and Elevar sign a global strategic partnership for the commercialization of Apealea®